VF
CURX

Virtu Financial’s Curanex Pharmaceuticals CURX Stock Holding History

Virtu Financial’s Portfolio CURX Stock Details CURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14K Buy
+51,236
New +$18.7K ﹤0.01% 1402

Other funds holding CURX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Virtu Financial's CURX Position: Q2 2026 in Review

Virtu Financial opened a new position in Curanex Pharmaceuticals (CURX) in Q2 2026: 51,236 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #1402 among its holdings.

6 funds tracked by Wall St. Rank hold CURX as of Q2 2026.

  • Virtu Financial held 51,236 shares of Curanex Pharmaceuticals worth $14K as of Q2 2026.
  • Curanex Pharmaceuticals was a new Virtu Financial position in Q2 2026.
  • Curanex Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1402 holding.
  • 6 funds tracked by Wall St. Rank held Curanex Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.